{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T07:25:28Z","timestamp":1787297128055,"version":"build-2736575974"},"reference-count":5,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Lauletta et al. (Clin Exp Dermatol 2026; 51:612\u201319) provide important real-world evidence on paradoxical psoriasis and seronegative spondyloarthropathy during interleukin (IL)-4\/IL-13 blockade in atopic dermatitis. However, an important unanswered question is whether paradoxical psoriasis represents an early clinical marker of subsequent inflammatory arthritis rather than an isolated adverse event. Clarifying this relationship could inform targeted musculoskeletal surveillance and improve early diagnosis and long-term outcomes.<\/jats:p>","DOI":"10.1093\/ced\/llag330","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:54:26Z","timestamp":1784807666000},"source":"Crossref","is-referenced-by-count":0,"title":["Should paradoxical psoriasis trigger rheumatological surveillance during interleukin (IL)-4\/IL-13 blockade?"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1188-0918","authenticated-orcid":false,"given":"Ercan","family":"Y\u0131lmaz","sequence":"first","affiliation":[{"name":"Inonu University, Faculty of Medicine, Pediatric Allergy and Immunology Department , Malatya ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3962-9397","authenticated-orcid":false,"given":"Nezihe","family":"K\u00f6ker \u00d6zer","sequence":"additional","affiliation":[{"name":"Inonu University, Faculty of Medicine, Pediatric Allergy and Immunology Department , Malatya ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4439-2689","authenticated-orcid":false,"given":"Erdem","family":"Topal","sequence":"additional","affiliation":[{"name":"Inonu University, Faculty of Medicine, Pediatric Allergy and Immunology Department , Malatya ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"2026082103110955400_llag330-B1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/ced\/llaf483","article-title":"Psoriasis and seronegative spondyloarthropathy in patients with atopic dermatitis treated with dupilumab or tralokinumab: a multicentre observational study","volume":"51","author":"Lauletta","year":"2026","journal-title":"Clin Exp Dermatol"},{"key":"2026082103110955400_llag330-B2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","article-title":"Diagnostic delay of more than 6\u2005months contributes to poor radiographic and functional outcome in psoriatic arthritis","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2026082103110955400_llag330-B3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/ard-2024-225531","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update","volume":"83","author":"Gossec","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026082103110955400_llag330-B4","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.jid.2022.03.013","article-title":"T helper 2 IL-4\/IL-13 dual blockade with dupilumab is linked to some emergent T helper 17-type diseases, including seronegative arthritis and enthesitis\/enthesopathy, but not to humoral autoimmune diseases","volume":"142","author":"Bridgewood","year":"2022","journal-title":"J Invest Dermatol"},{"key":"2026082103110955400_llag330-B5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ced\/llad390","article-title":"Dupilumab-associated inflammatory arthritis: a literature review","volume":"49","author":"Napolitano","year":"2024","journal-title":"Clin Exp Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag330\/69966217\/llag330.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag330\/69966217\/llag330.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T07:11:12Z","timestamp":1787296272000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/advance-article\/doi\/10.1093\/ced\/llag330\/8741594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":5,"URL":"https:\/\/doi.org\/10.1093\/ced\/llag330","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"article-number":"llag330"}}